Clinical Trial

A Study of SYH2082 Injection in Healthy Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the safety and tolerability of single dose of SYH2082 Injection in healthy participants.
Trial Details
NCT Number NCT07736404
Lead Sponsor CSPC Ouyi Pharmaceutical Co., Ltd.
Conditions Overweight or Obesity
Enrollment 50 participants
Start Date 2026-04-13
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-30